Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China.
Jiang, Minghuan; Li, Pengchao; You, Joyce Hoi-Sze; Zheng, Xinglong; Deng, Jizhao; Zhao, Mingyue; Feng, Liuxin; Fang, Yu.
Afiliación
  • Jiang M; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
  • Li P; Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, China.
  • You JH; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
  • Zheng X; Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, China.
  • Deng J; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong, China SAR.
  • Zhao M; Department of Cardiovascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Feng L; Department of Cardiovascular Medicine, Shaanxi Provincial People's Hospital, Xi'an, China.
  • Fang Y; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
PLoS One ; 14(12): e0224580, 2019.
Article en En | MEDLINE | ID: mdl-31790409

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Prevención Primaria / Enfermedades Cardiovasculares / Aspirina / Análisis Costo-Beneficio / Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Prevención Primaria / Enfermedades Cardiovasculares / Aspirina / Análisis Costo-Beneficio / Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: China